Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke.

Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Abstract Text:

Jordan Kharofa,Padmini Sekar,Mary Haverbusch,Charles Moomaw,Matthew Flaherty,Brett Kissela,Joseph Broderick,Daniel Woo,

BACKGROUND AND PURPOSE: Selective serotonin reuptake inhibitors (SSRI) are widely prescribed. Several reports have observed an increased bleeding risk associated with SSRI use, which is hypothesized to be secondary to their antiplatelet effect. METHODS: We tested the hypothesis that SSRIs increase the risk for or potentiate the risk of hemorrhagic stroke associated with antiplatelets and anticoagulants. RESULTS: In multivariate analysis, we found no increased risk associated with SSRI use for intracerebral hemorrhage (odds ratio=1.1, 95% CI: 0.7 to 1.8; P=0.63) or subarachnoid hemorrhage (odds ratio=0.6, 95% CI: 0.4 to 1.0; P=0.054). In addition, potentiation of risk with warfarin or antiplatelets was not observed. CONCLUSIONS: Further studies with larger populations would be needed to exclude a small increase in intracranial hemorrhage risk with SSRI use.

Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Publishing Authors By Initials

J Kharofa,P Sekar,M Haverbusch,C Moomaw,M Flaherty,B Kissela,J Broderick,D Woo,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Journal Published:

PUBLICATION TYPE: Letter

Journal: Stroke; a journal of cerebral circulation

VOLUME: 38

Page Numbers: 3049-51

Journal Abbreviation: Stroke

ISSN: 1524-4628

DAY: 27

MONTH: 09

YEAR: 2007

Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 235266

Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke.

AFFILIATION:

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Stroke

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke Related Publications

• A normative study of the Revised Hasegawa Dementia Scale: comparison of demographic influences between the Revised Hasegawa Dementia Scale and the Mini-Mental Status Examination.
• An assessment of sampling, preservation, and analytical procedures for arsenic speciation in potentially contaminated waters.
• Association analysis of G72/G30 polymorphisms with schizophrenia in the Korean population.
• Bacteriology, inflammation, and healing: a study of nanocrystalline silver dressings in chronic venous leg ulcers.
• Cerebrospinal fluid leak after anterior cervical disc fusion: an unusual cause of dysphagia and neck mass.
• Conductivity imaging of canine brain using a 3 T MREIT system: postmortem experiments.
• Correction in female PKU mice by repeated administration of mPAH cDNA using phiBT1 integration system.
• Cross-cultural validation of the London Handicap Scale and comparison of handicap perception between Chinese and UK populations.
• Determination of Flavonoids in Seeds of Zizyphus vulgaris var. spinosus by High Performance Liquid Chromatography.
• Field-in-field technique with intrafractionally modulated junction shifts for craniospinal irradiation.
• Gene expression by fibroblasts seeded on small intestinal submucosa and subjected to cyclic stretching.
• Genetic and environmental risk factors and their interactions for Parkinson's disease in a Chinese population.
• High-risk repair of ascending aortic aneurysm due to giant cell aortitis.
• Location and outcome of anticoagulant-associated intracerebral hemorrhage.
• New cis-Khellactone Esters from Angelica flaccida.
• Perimesencephalic subarachnoid hemorrhage: incidence, risk factors, and outcome.
• Preparation and control-release kinetics of isosorbide dinitrate microspheres.
• Prevalence and diversity of qnr alleles in AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii and Serratia marcescens: a multicentre study from Korea.
• Protection against Cryptobia (Trypanoplasma) salmositica and Salmonid Cryptobiosis.
• Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke.
• Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial.
• Stability of adolescent body mass index during three years of follow-up.
• Susceptibility of sexually mature rainbow trout, Oncorhynchus mykiss to experimental cryptobiosis caused by Cryptobia salmositica.
• The development and validation of a charge-coupled device laser reflectance system to measure the complex cross-sectional shape and area of soft tissues.
• The revolving door syndrome: the Chinese COPD patients' perspectives.
• The role of race in time to treatment after subarachnoid hemorrhage.
• Transposed arteriovenous fistulae: do the results justify the effort?
• Triterpenoid Glycosides from the Roots of Patrinia scabiosaefolia.
• Two New Saponins from Phytolacca americana.
• When the differential diagnosis of fever is malaria, malaria, malaria...